Overview

Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function.

Status:
Completed
Trial end date:
2021-07-05
Target enrollment:
Participant gender:
Summary
Study of pharmacokinetics and safety of apraglutide in participants with normal and impaired kidney function.
Phase:
Phase 1
Details
Lead Sponsor:
VectivBio AG